human | Q5 |
P10949 | IRIS UNICAMPANIA author ID | 04444 |
P496 | ORCID iD | 0000-0003-2817-8436 |
P1153 | Scopus author ID | 55410853200 |
7004951151 |
P735 | given name | Evangelista | Q3735207 |
Evangelista | Q3735207 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q37090659 | A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C. |
Q42287432 | Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C. |
Q43760925 | Abnormal steroid sulfate in plasma of women with intrahepatic cholestasis of pregnancy |
Q78414181 | Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer |
Q43046943 | Absence of occult HCV infection in HIV-positive patients. |
Q43037083 | Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases |
Q34675557 | Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy |
Q43042294 | Acute hepatitis B and C virus coinfection: a virological and clinical study of 3 cases. |
Q43510018 | Acute hepatitis B in children with papular acrodermatitis. |
Q42232261 | Acute hepatitis C: a 24-week course of pegylated interferon α-2b versus a 12-week course of pegylated interferon α-2b alone or with ribavirin |
Q38195262 | Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment |
Q45405567 | Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection |
Q67682386 | Acute viral hepatitis in Italy. Results of a collaborative study |
Q38207725 | Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection |
Q47586705 | An update on the treatment options for HBV/HCV coinfection |
Q42234731 | Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. |
Q42222997 | Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients |
Q36319267 | Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop |
Q50707984 | Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C. |
Q40595308 | Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis |
Q71707650 | Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis |
Q39541014 | CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. |
Q42490118 | Can HCV affect the efficacy of anti-HIV treatment? |
Q28539814 | Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C |
Q40113130 | Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients |
Q42999777 | Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases |
Q39494125 | Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology |
Q44769298 | Characteristics of liver cirrhosis in Italy: results from a multicenter national study |
Q43047852 | Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection |
Q72715292 | Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen |
Q42210385 | Clinical and virological characteristics associated with severe acute hepatitis B. |
Q45417133 | Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection |
Q38074390 | Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection |
Q71190327 | Clinical aspects of delta agent infection in southern Italy |
Q47828777 | Clinical experience with daptomycin in Italy: results from a registry study of the treatment of Gram-positive infections between 2006 and 2009. |
Q38779980 | Clinical impact of the hepatitis C virus mutations in the era of directly acting antivirals |
Q67760965 | Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases |
Q42266477 | Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. |
Q26773676 | Clinical significance of hepatitis B surface antigen mutants |
Q70032258 | Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies |
Q90894096 | Correction to: HBV molecular epidemiology and clinical condition of immigrants living in Italy |
Q36845533 | D-penicillamine in the treatment of active chronic diseases of the liver. Preliminary data |
Q43902489 | Dane particles-associated hepatitis B core antigen in patients with HBsAg-positive chronic hepatitis |
Q39419904 | Decrease in HDV endemicity in Italy. |
Q91560021 | Decreasing role of HCV and HBV infections as aetiological factors of hepatocellular carcinoma in Italy |
Q43524889 | Delta agent infection: an unfavourable event in HBsAg positive chronic hepatitis |
Q93636871 | Detection of two forms of HBeAg (free-and IgG-bound HBeAg) in patients with HBe antigenemia using staphylococcus bearing protein A |
Q54523160 | Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. |
Q45483149 | Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres |
Q30702953 | Differential diagnosis between benign and malignant biliary tract obstruction: discriminative usefulness of some clinical and laboratory data |
Q77297242 | Does HIV infection favor the sexual transmission of hepatitis C? |
Q71039706 | Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe |
Q39544689 | Effect of prednisone priming followed by alfa-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial |
Q34514292 | Efficacy of Pegylated interferon α-2a and α-2b in patients with genotype 1 chronic hepatitis C: a meta-analysis |
Q31107505 | Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey |
Q92193515 | Epidemiological and etiological variations in hepatocellular carcinoma |
Q44126919 | Epidemiological evaluations of human immunodeficiency virus, herpes simplex virus type 1 and 2 and cytomegalovirus infections in drug addicts |
Q69244912 | Epidemiology of HDV infection in Southern Italy |
Q33801300 | Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy |
Q64971879 | Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients. |
Q92410137 | Erratum to "Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients" |
Q38679799 | Etiological factors of chronic hepatitis in Italy: a 2014 national survey |
Q39494196 | Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study |
Q81643918 | Exposure to HAV infection in patients with chronic liver disease in Italy, a multicentre study |
Q52295303 | Factors affecting the changes in molecular epidemiology of acute hepatitis B in a Southern Italian area. |
Q42287905 | Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. |
Q42255783 | Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection |
Q43898328 | Familial clustering of hepatitis B antigen and liver diseases in families with a high incidence of viral hepatitis |
Q37544514 | Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment. |
Q42215454 | Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection |
Q47573260 | Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy |
Q59361085 | Genotype I hepatitis A virus introduction in Italy: Bayesian phylogenetic analysis to date different epidemics |
Q70610131 | Geographic differences in HBV related, autoimmune, and cryptogenic chronic active hepatitis |
Q45125334 | HAV replication in acute hepatitis with typical and atypical clinical course |
Q39355216 | HBV and HCV chronic hepatitis and cirrhosis. |
Q56335074 | HBV molecular epidemiology and clinical condition of immigrants living in Italy |
Q46099371 | HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. |
Q43040641 | HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. |
Q43032349 | HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease |
Q92724455 | HDV infection in immigrant populations |
Q95277079 | HIV-1 recombinant forms in immigrants regularly residing in Milan, northern Italy |
Q34545899 | Helicobacter spp. and liver diseases. |
Q33735206 | Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection |
Q38722666 | Hepatitis A virus strains circulating during 1997-2015 in Campania, a Southern Italy region with periodic outbreaks |
Q39000397 | Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. |
Q45866904 | Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology |
Q26765801 | Hepatitis B virus and hepatitis C virus infection in healthcare workers |
Q36269649 | Hepatitis B virus burden in developing countries |
Q26771150 | Hepatitis B virus infection in immigrant populations |
Q37633770 | Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features |
Q38952987 | Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013. |
Q90564809 | Hepatitis C late relapse in patients with directly acting antiviral-related sustained virological response at week 12 |
Q26785981 | Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment |
Q45758599 | Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: a multicentre case-control study |
Q26782033 | Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals |
Q42996903 | Hepatitis C virus superinfection in hepatitis B virus chronic carriers: a reciprocal viral interaction and a variable clinical course |
Q39494133 | Hepatitis delta infection in Italian patients: towards the end of the story? |
Q42985026 | Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study (a report from the HCV study group of the Italian Association for the Study of the Liver). |
Q41584146 | Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration |
Q58863669 | High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients |
Q59286728 | Human hepatitis E virus circulation in Bulgaria: Deep Bayesian phylogenetic analysis for viral spread control in the country |
Q59353516 | Human hepatitis E virus circulation in Bulgaria: Deep Bayesian phylogenetic analysis for viral spread control in the country |
Q71274450 | Immunosuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. A report from a study group for CAH of the Italian Association for the study of the liver |
Q44245592 | Immunosuppressive therapy of HBsAg-positive chronic active hepatitis in childhood: a multicentric retrospective study on 139 patients. |
Q40819897 | Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C. |
Q35886670 | Impact of comorbidities on the severity of chronic hepatitis B at presentation |
Q45414950 | Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy |
Q42991017 | Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index |
Q71005011 | In vitro synthesis of IgG and IgM in patients with HBsAg-positive and HBsAg-negative chronic active hepatitis |
Q43040173 | Increased hepatitis C viral load and reactivation of liver disease in HCV RNA-positive patients with onco-haematological disease undergoing chemotherapy |
Q34283736 | Infection with the delta agent in chronic HBsAg carriers |
Q40559662 | Infectious diarrhoeas |
Q69705157 | Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis |
Q42985571 | Influence of chronic coinfection with hepatitis B and C virus on liver histology. |
Q39419887 | Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study |
Q34263370 | Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression |
Q67970214 | Interaction between HDV and HBV infection in HBsAg-chronic carriers |
Q40182428 | Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation. |
Q45749997 | Intrafamilial transmission of hepatitis delta virus: molecular evidence. |
Q44481046 | Is liver biopsy necessary for hepatitis C virus carriers with persistently normal aminotransferase levels? |
Q43035645 | Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment. |
Q39320945 | Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis |
Q59306868 | Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons |
Q59306861 | Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 |
Q42257697 | Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. |
Q39004446 | Lipodystrophy and serum lipid abnormalities in HIV-positive sub-Saharan population on ART. |
Q26777511 | Liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact |
Q44269399 | Liver histology in 34 "HPsAg long-term healthy carriers |
Q43085980 | Liver histology in HIV/hepatitis C-coinfected and HCV-monoinfected patients with persistently normal alanine aminotransferases |
Q34811974 | Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression |
Q42991587 | Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment. |
Q33648849 | Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf |
Q38135971 | Management of infections in cirrhotic patients: report of a consensus conference |
Q38175238 | Management of infections pre- and post-liver transplantation: report of an AISF consensus conference |
Q39224652 | Molecular diversity in irregular or refugee immigrant patients with HBV-genotype-E infection living in the metropolitan area of Naples |
Q89530878 | Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy |
Q42209108 | Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region |
Q45819082 | Morphometric study on the distribution of liver necrosis in experimental murine hepatitis by MHV-3 virus |
Q58811116 | Multicenter trial on the efficacy of HBIG and vaccine in preventing perinatal hepatitis B. Final report |
Q40779997 | Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B. |
Q36292486 | Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C. |
Q37641840 | Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study. |
Q38807875 | Occult HBV infection in the oncohematological setting |
Q41221366 | Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B. |
Q35146790 | Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors |
Q39409509 | Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency |
Q69588210 | Pharmacokinetics of ciprofloxacin in impaired liver function |
Q44251554 | Polymerase chain reaction (PCR) for the detection of HIV proviral DNA (pDNA) in subjects at risk of infection |
Q45257444 | Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in antiretroviral-naive HIV patients in Campania, Italy |
Q68204231 | Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study |
Q70265734 | Radioimmunoassay for HBcAg |
Q70271572 | Radioimmunoassay for hepatitis B core antigen |
Q61054082 | Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B |
Q38226627 | Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT). |
Q37838047 | Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients |
Q38870182 | Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). |
Q50283938 | Reply: To PMID 24442928. |
Q59355074 | Resistance detection and re-treatment options in hepatitis C virus-related chronic liver diseases after DAA-treatment failure |
Q52046648 | Risk management of HBsAg or anti-HCV positive healthcare workers in hospital. |
Q36167378 | Rituximab-based treatment, HCV replication, and hepatic flares |
Q41140604 | Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment |
Q35779058 | Role of genetic polymorphisms in hepatitis C virus chronic infection |
Q42245958 | Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection |
Q26823538 | Role of occult hepatitis B virus infection in chronic hepatitis C |
Q50103925 | Salmonella non-typhoid infection: new epidemiological findings |
Q44837822 | Serum anti-HIV IgA in seropositive patients and in subjects at risk of HIV infection |
Q72429104 | Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis |
Q42996972 | Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells |
Q41549262 | TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism |
Q40482870 | TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype. |
Q67377058 | The differential diagnosis between intrahepatic cholestatic jaundice and viral hepatitis during pregnancy |
Q40911738 | The epidemiology of hepatitis delta infection in Italy over the last 18 years. |
Q45147822 | The epidemiology of hepatitis delta infection in Italy. Promoting Group |
Q72802594 | The etiology of chronic hepatitis in Italy: a multicenter study |
Q40257964 | The growth-hormone in long-term steroid-treated patients with chronic active hepatitis |
Q41443935 | The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. |
Q40445497 | The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. |
Q35224155 | The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy |
Q93055970 | The phylogenetic approach for viral infectious disease evolution and epidemiology: An updating review |
Q72903106 | The role of H2 antagonists in perennial allergic rhinitis |
Q67348486 | The significance of the Australia antigen (HBsAg) persistent healthy carrier "status": a long-term follow-up study of 34 cases |
Q54490638 | Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection. |
Q45355787 | Transient reactivation of occult hepatitis B virus infection despite lamivudine prophylaxis in a patient treated for non-Hodgkin lymphoma |
Q71052149 | Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study |
Q43605323 | Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study. |
Q37833228 | Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. |
Q38352572 | Treatment of chronic hepatitis C in patients with HIV/HCV coinfection |
Q81229927 | Trends of aetiological factors of hepatocellular carcinoma in Italy |
Q47177581 | VIROLOGICAL PATTERNS OF HCV PATIENTS WITH FAILURE TO INTERFERON-FREE REGIMENS. |
Q43000718 | Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis |
Q43040669 | Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients |
Q30795477 | Virological and clinical aspects of multiple hepatitis virus infections: preliminary data of an italian multicentre study |
Q42989673 | Virological and epitope evolution of HCV infection from acute hepatitis C to subsequent episodes of HCV-related acute liver cell necrosis |
Q47556549 | What is changed in HBV molecular epidemiology in Italy? |
Q79805765 | [Anti-HAV screening patients with chronic hepatitis] |
Q62727429 | [HIV Antigens as complement fixing circulating immune complexes] |
Q76333970 | [Hepatitis viruses and development of hepatocellular carcinoma] |
Q71396677 | [Histochemical studies on the RNA content of the liver and pancreas of mice in ethionine poisoning] |
Q73664023 | [Laboratory diagnosis of HIV infection] |
Q70885081 | [Maternal-fetal transmission of hepatitis B virus. Follow-up study of 21 infants born to HBSAG-positive mothers, and 6 born to HBSAG-negative mothers with anti-HBV antibodies] |
Q45929117 | [Spontaneous and treatment-induced virological dynamic in the plasma, PBMC and liver tissue in a patient with chronic HBV and HCV coinfection]. |
Q71910711 | [The role of IFN in the therapy of chronic delta hepatitis] |
Search more.